| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
|---|
| 10/21/2009 | CN101560192A 2-oxazoline derivant and preparation method thereof |
| 10/21/2009 | CN101560191A Alpha-menaphthyl substituted spiro bis(oxazoline) ligands, synthetic method and application thereof in synthesizing pyrazolidine derivatives |
| 10/21/2009 | CN101559053A 5-membered heterocycle derivatives, production thereof and use thereof as medicaments |
| 10/20/2009 | US7605270 Polymorphic forms of (S).-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) benzylcarbamate |
| 10/20/2009 | US7605176 β-ketoamide compounds with MCH antagonistic activity |
| 10/20/2009 | US7605163 Benzoyl-piperazine derivatives |
| 10/20/2009 | CA2585898C Use of (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4-thaizolyl)methyl)amino)-carbonyl)valinyl)amino)-2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane in combination with another protease inhibitor for treating hiv infection |
| 10/20/2009 | CA2358951C Reverse hydroxamate inhibitors of matrix metalloproteinases |
| 10/15/2009 | WO2009105214A3 Selective androgen receptor modulators |
| 10/15/2009 | WO2009056811A3 Tetrahydrobenzothiazole derivatives with dopamine receptor activity |
| 10/15/2009 | WO2008145615A3 Aminoazoline and urea derivatives for combating animal pests |
| 10/15/2009 | US20090258917 Benzoxazoles Useful in the Treatment of Inflammation |
| 10/15/2009 | US20090258884 Substituted amides |
| 10/14/2009 | EP2108014A1 Method of preparing docetaxel and intermediates used therein |
| 10/14/2009 | EP1971573B1 Processes for preparing intermediate compounds useful for the preparation of ezetimibe |
| 10/14/2009 | EP1720829B1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors |
| 10/14/2009 | CN101558051A Method of preparing docetaxel and intermediates used therein |
| 10/14/2009 | CN101555212A Synthesized micromolecule compound capable of conveying bioactivator and application thereof |
| 10/14/2009 | CN100549007C Broadspectrum 2-amino-benzoxazole sulfonamide HIV protease inhibitors |
| 10/13/2009 | US7601745 Nuclear factor kappa beta (NF-kB) inhibitors such as [4-(1H-Indol-3-yl)-piperidin-1-yl]-{2-[1-(pyrazine-2-carbonyl)-piperidin-4-yl]-thiazol-4-yl}-methanone |
| 10/13/2009 | US7601721 Substituted heterocyclic compounds |
| 10/08/2009 | WO2009123316A1 Heterocyclic derivative and use thereof |
| 10/08/2009 | WO2009123241A1 Inhibitor of plasminogen activator inhibitor-1 |
| 10/08/2009 | WO2009123164A1 Heterocyclic derivative having inhibitory activity on endothelial lipase |
| 10/08/2009 | US20090253905 Process for the preparation of onium salts with alkyl- or arylsulfonate anions or alkyl- or arylcarboxylate anions having a low halide content |
| 10/08/2009 | US20090253762 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity |
| 10/08/2009 | US20090253758 Selective androgen receptor modulators |
| 10/08/2009 | US20090253699 Compounds for Nonsense Suppression, and Methods for Their Use |
| 10/08/2009 | US20090253685 Product comprising at least one Cdc25 phosphatase inhibitor in combination with at least one other anti-cancer agent |
| 10/08/2009 | US20090253659 Cycloalkylidene Compounds As Modulators of Estrogen Receptor |
| 10/08/2009 | CA2720343A1 Heterocyclic derivative and use thereof |
| 10/07/2009 | CN101553463A New pharmaceutical intermediates in the synthesis of ace- inhibitors and the use thereof |
| 10/07/2009 | CN101550166A Electric phosphorescent alpha-pinene derivant metal complex |
| 10/07/2009 | CN101550110A Preparation method of D-threo-2-(dichloromethyl)-4, 5-dihydro-5-(p-(methylsulfonyl) phenyl)-4-oxazole methanol |
| 10/07/2009 | CN100546984C Method for preparing herbicide fenoxaprop-p-ethyl |
| 10/07/2009 | CN100546983C Synthesis method of 3-phenethyl oxazolidine 2,4-diketone |
| 10/07/2009 | CN100546976C Nitroaniline-based alkylating agents and their use as prodrugs |
| 10/06/2009 | US7598666 Rubrene derivatives emit blue light; glass substrate supports a hole injecting layer, a hole transporting layer, and a light emitting layer |
| 10/06/2009 | US7598395 Heterocyclocarboxamide derivatives |
| 10/06/2009 | US7598389 Silylated carboxamides |
| 10/06/2009 | US7598386 Sulphones which modulate the action of gamma-secretase |
| 10/06/2009 | US7598281 2-[3-(5-Methyl-2-m-tolyloxazol-4-ylmethoxymethyl)cyclohexylcarbamoyl]cyclobutanecarboxylic acid; modulation and control lipid and/or carbohydrate metabolism |
| 10/06/2009 | US7598266 Fused heterocyclic derivatives as PPAR modulators |
| 10/06/2009 | US7598245 Pyruvate dehydrogenase kinase, c-KIT, cyclin-dependent kinases, Janus kinases, FLT3 kinase, AUR-2 kinase, tyrosine kinase; 1-(2-amino-4-pyridyl)-3-phenylaminotriazoles; combination therapy with antiallergens, immunomodulators, antiproliferative agents; Alzheimer's, Parkinson's, Multiple Sclerosis, asthma |
| 10/01/2009 | US20090247534 New compounds |
| 10/01/2009 | US20090247506 Antibacterial agents |
| 10/01/2009 | US20090246232 Pharmaceutical composition |
| 09/30/2009 | EP1692117B1 Oxazole derivatives of tetracyclines |
| 09/30/2009 | CN101544578A Preparing method for phenyl acetic acid derivates and applications in medicament |
| 09/30/2009 | CN100545161C Heterocyclic derivatives their preparing methods and uses |
| 09/30/2009 | CN100545151C Oxazole derivatives of tetracyclines |
| 09/30/2009 | CN100545150C Pyridine ring containing oxazolidinone compounds and preparation process and application thereof |
| 09/29/2009 | US7595399 Tyrosine derivatives |
| 09/29/2009 | US7595344 Sulphones which modulate the action of gamma secretase |
| 09/29/2009 | US7595343 Inhibitors of histone deacetylase |
| 09/29/2009 | US7595334 Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors |
| 09/29/2009 | US7595332 Such as N-(4-tert-butylphenyl)-4-(2-pyridinyl)benzamide for treatment of urinary incontinence, pain, inflammatory thermal hyperalgesia, and/or bladder overactivity |
| 09/24/2009 | WO2009117109A1 Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 |
| 09/24/2009 | WO2009115491A1 Azolin-2-ylamino compounds for combating animal pests |
| 09/24/2009 | US20090239907 Methods and compositions for treating fish diseases |
| 09/24/2009 | US20090239841 Diaryl Ureas as CB1 Antagonists |
| 09/24/2009 | US20090239798 Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide |
| 09/24/2009 | CA2718264A1 Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 |
| 09/23/2009 | EP2103603A1 Method for producing pyrrolidine compound |
| 09/23/2009 | EP2102177A1 Benzoxazoles useful in the treatment of inflammation |
| 09/23/2009 | EP2102162A1 Phenylic derivatives and use thereof as drugs |
| 09/23/2009 | CN100543017C Novel keto-oxadiazole derivatives as cathepsin inhibitors |
| 09/22/2009 | US7592361 Indole acetic acid derivatives and their use as pharmaceutical agents |
| 09/22/2009 | CA2487450C (2s)-2-ethylphenylpropanoic acid derivatives |
| 09/22/2009 | CA2454584C Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising ep4 agonist as active ingredient |
| 09/17/2009 | WO2009113320A1 Mmp inhibitor |
| 09/17/2009 | WO2009027785A3 1, 3-oxazole derivatives as cetp inhibitors |
| 09/17/2009 | US20090234133 Ionic Liquids |
| 09/16/2009 | EP2100884A1 Crystalline form of linezolid |
| 09/16/2009 | EP2099743A2 Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof |
| 09/16/2009 | CN100540547C Inhibitors of histone deacetylase |
| 09/16/2009 | CN100540538C Large conductance calcium-activated k channel opener |
| 09/15/2009 | US7589094 N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 09/11/2009 | WO2009021749A8 Preparation of a compound for the treatment of duchenne muscular dystrophy |
| 09/11/2009 | CA2715835A1 Amide compounds, compositions and uses thereof |
| 09/09/2009 | EP1673370B1 Crystalline form of linezolid |
| 09/09/2009 | CN101528717A Thiazole and oxazole-substituted arylamides |
| 09/08/2009 | US7585880 Phenylpropanoic acid derivatives |
| 09/08/2009 | US7585878 2-[(2,5-dimethylpyrrolidin-1-yl)methyl]-N-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)biphenyl-4-carboxamide; capsaicin receptor VR1 inhibitory activity; inflammatory pain and neurogenic pain, migraine, cluster headache, bladder diseases including overactive bladder |
| 09/08/2009 | CA2465342C Optically active herbicidal (r)-phenoxypropionic acid-n-methyl-n-2-fluorophenyl amides |
| 09/03/2009 | WO2009106021A1 Intermediates for the preparation of (3r, 4s) -1- (4-fluorophenyl) -3- [ (3s) -3- (4-fluorophenyl) -3-hydroxypropyl) ] -4- (4-hydroxyphenyl) -2-azetidinone |
| 09/03/2009 | US20090221586 Oxazole compound and pharmaceutical composition |
| 09/03/2009 | US20090220454 Use of the histone deacetylase inhibitor N-hydroxy-4-[2-(3-dimethylaminobenzofuran-2-ylcarbonylamino)ethoxy]benzamide (aka CRA-24781, PCI-24781) for treating myelogenous leukemia (MML) or acute myelogenous leukemia (AML), optionally in combination therapy |
| 09/02/2009 | EP2096490A1 Display element and method of driving the same |
| 09/02/2009 | EP2096104A1 Organic diamines as mGluR7 modulators |
| 09/02/2009 | EP1885703A4 Processes for production of phenolic 4-biphenylylazetidin-2-ones |
| 09/02/2009 | CN101519386A Large conductance calcium-activated K channel opener |
| 09/02/2009 | CN101519384A Chiral oxazoline and synthesis method thereof |
| 09/01/2009 | USRE40901 14- Beta -hydroxy-1,14-carbonate-baccatine III and V derivatives, 13-substituted by an isoserine residue; remarkable cytotoxic and anticarcinogenic-agent activities; capable of overcoming the resistance of cell lines expressing the multidrug resistant phenotype; breast, ovarian, colon cancers |
| 09/01/2009 | US7582794 2-(3-Hydroxyphenoxymethyl)-6-methylbenzoic Acid as chemical intermediate for synthesizing PPAR agonists and antagonists |
| 09/01/2009 | US7582668 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
| 09/01/2009 | US7582666 Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1,3-oxazolines and their use as anticoagulant and antithrombotics |
| 09/01/2009 | US7582659 effective against aerobic and anerobic pathogens such as multi-resistant staphylococci, streptococci and enterococci; 1-[5(R)-3-[4-[2-[(1 alpha ,5 alpha ,6 beta )-6-Cyano-3-azabicyclo[3.1.0]hexan-6-yl]pyridin-5-yl]-3-fluorophenyl]-2-oxooxazolidin-5-ylmethyl]-1,2,3-triazole; side effect reduction |
| 09/01/2009 | US7582657 Vanilloid receptor ligands and their use in treatments |
| 09/01/2009 | CA2367368C Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands |